PVLA

Palvella Therapeutics Inc

May 18 • 04:00PM ET

105.05

-9.19 -8.04 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ARQT ANAB ZURA KRYS KYMR

| Held by: VTI XBI IWM VXF IWO VTWO VHT VFMO IWC LABU

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.17	Insider Own	26.64%	Shs Outstand	15.74M	Perf Week	-13.96%
Market Cap	1.51B	Forward P/E	-	EPS next Y	-6.43	Insider Trans	-0.49%	Shs Float	10.35M	Perf Month	-19.20%
Enterprise Value	1.26B	PEG	-	EPS next Q	-1.16	Inst Own	83.54%	Short Float	20.97%	Perf Quarter	31.16%
Income	-49.30M	P/S	-	EPS this Y	-49.61%	Inst Trans	32.19%	Short Ratio	7.23	Perf Half Y	30.50%
Sales	0.00M	P/B	7.12	EPS next Y	-15.88%	ROA	-28.73%	Short Interest	2.17M	Perf YTD	0.36%
Book/sh	14.76	P/C	5.75	EPS next 5Y	16.23%	ROE	-34.25%	52W High	151.18 -30.51%	Perf Year	376.42%
Cash/sh	18.26	P/FCF	-	EPS past 3/5Y	53.08% 41.62%	ROIC	-106.76%	52W Low	20.20 420.05%	Perf 3Y	52.92%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.58% 6.24%	Perf 5Y	-31.61%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	66.94%	Oper. Margin	-	ATR (14)	8.07	Perf 10Y	-23.66%
Dividend Ex-Date	-	Quick Ratio	5.20	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	35.04	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	28.88	EPS Q/Q	-62.12%	SMA20	-15.03%	Beta	-0.12	Target Price	228.47
Payout	-	Debt/Eq	0.08	Sales Q/Q	-	SMA50	-15.16%	Rel Volume	1.02	Prev Close	114.24
Employees	29	LT Debt/Eq	0.08	Earnings	May 07 BMO	SMA200	16.05%	Avg Volume	300.26K	Price	105.05
IPO	Jan 02, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-28.34% -	Trades		Volume	305,429	Change	-8.04%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)